Covered recipient · General Payments record
MICHAEL COMER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,584.61
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $341.27 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $91.16 | 4 |
| ABBVIE INC. | $52.71 | 3 |
| Sumitomo Pharma America, Inc. | $38.89 | 2 |
| Abbott Laboratories | $35.77 | 2 |
| GlaxoSmithKline, LLC. | $29.11 | 2 |
| Otsuka America Pharmaceutical, Inc. | $22.16 | 1 |
| Novo Nordisk AS | $21.78 | 1 |
| Amgen Inc. | $18.63 | 1 |
| Corcept Therapeutics | $17.39 | 1 |
| PFIZER INC. | $13.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.60 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201865 | CMS |
| Abbott Laboratories | $20.17 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201867 | CMS |
| ABBVIE INC. | $20.27 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494578 | CMS |
| ABBVIE INC. | $17.60 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494580 | CMS |
| ABBVIE INC. | $14.84 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494582 | CMS |
| Amgen Inc. | $18.63 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115524392 | CMS |
| Corcept Therapeutics | $17.39 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117773075 | CMS |
| Dexcom, Inc. | $22.02 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153321966 | CMS |
| Dexcom, Inc. | $22.02 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153321968 | CMS |
| Dexcom, Inc. | $24.85 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153321970 | CMS |
| Dexcom, Inc. | $22.27 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153321972 | CMS |
| GlaxoSmithKline, LLC. | $15.49 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116728642 | CMS |
| GlaxoSmithKline, LLC. | $13.62 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116675199 | CMS |
| Novo Nordisk Inc | $21.78 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097518878 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.16 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118878574 | CMS |
| PFIZER INC. | $13.67 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131497757 | CMS |
| Sumitomo Pharma America, Inc. | $21.39 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148840002 | CMS |
| Sumitomo Pharma America, Inc. | $17.50 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148840004 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.